TRVN Trevena Inc

Trevena Inc is a clinical stage biopharmaceutical company. It discovers, develops and commercialize therapeutics that use a novel approach to target G protein coupled receptors.

$2.10  +0.02 (0.72%)
As of 03/05/2021 15:59:06 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
01/31/2014
157,030,012
4,261,030
$328,192,725
0.00%
SEC Edgar Online
10-Q
10-K
89532E109
US89532E1091
BGDW0N7

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-27.36
2.95
108.28
-21.26%
-780.04%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy